Mississauga, ON -- (SBWIRE) -- 09/24/2014 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Aethlon Medical Positions to Expand Hemopurifier Clinical Trials to Include Dengue Virus Treatment.”
Companies mentioned in this article include Aethlon Medical, Inc. (OTCQB:AEMD).
Article Excerpt:
Infections are a hot topic across the world currently. The Ebola outbreak, already the worst in history, is six months into it and still gaining steam. At its current pace, experts say that the number of Ebola cases in Liberia and Sierra Leone could top one million by the end of January, although it’s notable that the projections were calculated before a concerted response last week by the U.S. and other countries to accelerate efforts to control the outbreak. Separately, multi-drug antibiotic resistance has been streaming through headlines against the backdrop of President Obama signing an Executive Order last week to escalate efforts to develop new diagnostics and drugs to better combat the very real threat of a post-antibiotic era.
On Wednesday, Aethlon Medical, Inc. (OTCQB:AEMD) released news that it is looking to provide a new treatment for dengue virus, a leading cause of death and illness carried by mosquitoes in the tropics and subtropics with no approved drugs or vaccine therapies. Currently, according to the Centers for Disease Control and Prevention, the most effective protective measures are those that avoid mosquito bites. The CDC website states that up to 400 million people annually are infected with dengue virus.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/473/aethlon-medical-positions-to-expand-hemopurifier-clinical-trials-to-include-dengue-virus-treatment.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.